Protein Kinase C-Regulated Aβ Production and Clearance

Abstract EN

Alzheimer’s disease (AD) is the most common form of dementia among the elderly population.

AD, which is characterized as a disease of cognitive deficits, is mainly associated with an increase of amyloid β-peptide (Aβ) in the brain.

A growing body of recent studies suggests that protein kinase C (PKC) promotes the production of the secretory form of amyloid precursor protein (sAPPα) via the activation of α-secretase activity, which reduces the accumulation of pathogenic Aβ levels in the brain.

Moreover, activation of PKCα and mitogen-activated protein kinase (MAPK) is known to increase sAPPα.

A novel type of PKC, PKCε, activates the Aβ degrading activity of endothelin converting enzyme type 1 (ECE-1), which might be mediated via the MAPK pathway as well.

Furthermore, dysregulation of PKC-MAPK signaling is known to increase Aβ levels in the brain, which results in AD phenotypes.

Here, we discuss roles of PKC in Aβ production and clearance and its implication in AD.